⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
CGON
AMGN
JNJ
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
globenewswire.com
ONCY
From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story
accessnewswire.com
AMRX
ONCY